Bedrijfstakpensioenfonds Voor DE Media PNO continued to hold its position in CVS Health Corporation (NYSE:CVS) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,100 shares of the pharmacy operator’s stock at the end of the first quarter. Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings in CVS Health Corporation were worth $871,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Mercer Capital Advisers Inc. bought a new stake in shares of CVS Health Corporation during the first quarter worth $118,000. SRS Capital Advisors Inc. bought a new stake in shares of CVS Health Corporation during the fourth quarter worth $120,000. D Orazio & Associates Inc. raised its stake in shares of CVS Health Corporation by 34.5% in the fourth quarter. D Orazio & Associates Inc. now owns 1,560 shares of the pharmacy operator’s stock worth $123,000 after buying an additional 400 shares in the last quarter. Sowell Financial Services LLC bought a new stake in shares of CVS Health Corporation during the fourth quarter worth $140,000. Finally, Patriot Financial Group Insurance Agency LLC bought a new stake in shares of CVS Health Corporation during the fourth quarter worth $156,000. Institutional investors own 81.99% of the company’s stock.
CVS Health Corporation (CVS) opened at 78.64 on Monday. The stock has a 50 day moving average of $78.46 and a 200 day moving average of $79.38. CVS Health Corporation has a one year low of $69.30 and a one year high of $98.66. The firm has a market cap of $80.12 billion, a price-to-earnings ratio of 16.40 and a beta of 0.91.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.07. CVS Health Corporation had a net margin of 2.86% and a return on equity of 17.56%. The company had revenue of $44.51 billion during the quarter, compared to analysts’ expectations of $44.20 billion. During the same period in the prior year, the company posted $1.18 earnings per share. CVS Health Corporation’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts predict that CVS Health Corporation will post $5.87 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. The ex-dividend date is Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is presently 41.67%.
A number of analysts recently weighed in on the stock. Jefferies Group LLC set a $82.00 price target on shares of CVS Health Corporation and gave the company a “hold” rating in a report on Saturday, April 1st. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the company a “buy” rating in a report on Saturday, March 18th. Vetr lowered shares of CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price target for the company. in a report on Thursday, April 27th. Cowen and Company reissued an “outperform” rating and issued a $86.00 price target on shares of CVS Health Corporation in a report on Tuesday, June 13th. Finally, Needham & Company LLC assumed coverage on shares of CVS Health Corporation in a report on Tuesday, June 27th. They issued a “hold” rating for the company. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $93.98.
In other news, CFO David M. Denton sold 230,510 shares of the stock in a transaction on Monday, June 12th. The shares were sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the sale, the chief financial officer now directly owns 176,983 shares in the company, valued at $14,158,640. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Helena Foulkes sold 20,332 shares of the stock in a transaction on Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the sale, the executive vice president now owns 59,300 shares of the company’s stock, valued at $4,564,914. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 271,175 shares of company stock valued at $21,632,597. 0.61% of the stock is currently owned by corporate insiders.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284208/cvs-health-corporation-cvs-position-maintained-by-bedrijfstakpensioenfonds-voor-de-media-pno.html
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.